市場調查報告書
商品編碼
1466526
藥品包裝市場:按類型、交付模式、包裝水平、材料、最終用戶 - 2024-2030 年全球預測Pharmaceutical Packaging Market by Type (Ampoules, Blister Packs, Caps & Closures), Delivery Mode (Injectables, IV Drugs, Nasal), Level of Packaging, Material, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年藥品包裝市場規模為1,568.7億美元,預估2024年將達1,731.3億美元,2030年將達3,070.5億美元,複合年成長率為10.06%。
藥品包裝是指用於封裝和保護藥品的製程和材料。包括各種容器類型,如瓶子、管瓶、泡殼、管子、注射器、安瓿、封口、標籤和二次包裝。包裝旨在提供屏障保護、操作便利並傳達有關藥品的重要訊息。藥品包裝在確保藥品的安全、品質和有效性方面發揮著重要作用。藥品包裝有多種應用,包括提供對環境因素和兒童防護的屏障保護,以及滿足特定藥物輸送模式的要求。藥品包裝的主要最終使用者是藥品製造商、醫療保健提供者和患者。藥品包裝市場的成長受到多種因素的影響,包括用於患者參與和識別的智慧包裝的擴展、對初級藥品包裝的需求增加以及對生技藥品包裝的需求增加。此外,更嚴格的包裝法規(例如兒童防護和防篡改)也正在推動創新和合規相關投資。然而,藥品包裝的擴張受到藥品包裝原料價格變化、遵守全球和地區監管條件以及在保持包裝完整性的同時實現永續性目標的阻礙。同時,藥品包裝市場的最新機會包括奈米技術的進步和創新的新一代包裝解決方案、永續包裝解決方案的出現、個性化治療通訊協定客製化的包裝等。
主要市場統計 | |
---|---|
基準年[2023] | 1568.7億美元 |
預測年份 [2024] | 1731.3億美元 |
預測年份 [2030] | 3070.5億美元 |
複合年成長率(%) | 10.06% |
類型 防潮和防污染增加了藥品包裝中泡殼包裝的偏好
安瓿是小型密封玻璃或塑膠容器,用於封裝藥物樣本並保護它們免受空氣、污染和篡改。它們通常用於儲存液體藥品,非常適合一次性應用以保持無菌。泡殼包裝是預成型的塑膠包裝解決方案,可容納錠劑和膠囊,並提供針對濕度和污染物等外部因素的屏障。由於給藥方便、遵守用藥而被廣泛使用,從安全角度考慮,兒童用耐受性設計尤其受到青睞。蓋子和封口是藥品包裝的重要組成部分,確保產品的完整性和安全性。它們的範圍從簡單的螺旋蓋到複雜的兒童用防護和防篡改設計。藥筒在給藥中發揮重要作用,特別是在自行注射常見的情況下,例如糖尿病。藥筒是多劑量管瓶的替代品,是使用筆式注射器時的首選。標籤和配件對於藥品包裝至關重要,可作為品牌和資訊載體以及防偽工具。配備用於追蹤的 RFID 技術的智慧標籤和用於低溫運輸管理的溫度敏感標籤越來越受歡迎。寶特瓶是從液體糖漿到錠劑等多種藥品的常見包裝型態。它的需求量很大,因為它重量輕且耐用。重要的是,製造商正在專注於生產可回收的塑膠瓶,以減少對環境的影響。袋子通常用於粉狀和顆粒狀藥品,提供輕質且靈活的包裝解決方案。它特別適合需要防潮和避光的產品。預填充吸入器為使用者提供即用劑量的藥物,用於治療氣喘和慢性阻塞性肺病等疾病。預填充式注射器因其使用方便、劑量錯誤風險降低以及各種注射的高效輸送而普及。管瓶是通常用於盛裝液體藥物的小瓶子。它對於多藥物給藥至關重要,並因其與多種藥物的兼容性而受到重視。每種藥品包裝類型都滿足市場的不同需求。安瓿和管瓶適用於無菌性很重要的腸胃外應用。注射器和吸入器等預填充選項優先考慮便利性和劑量準確性。瓶子和袋子適用於成藥市場,在該市場中,運輸和儲存的便利性非常重要。泡殼包裝和藥筒由於其改善的患者依從性和易用性而變得越來越受歡迎。瓶蓋、瓶蓋、標籤和配件發揮整體支撐作用,注重產品安全並提供重要資訊。所有類別的最新趨勢是轉向永續材料和環保製造流程。
最終用戶:藥品製造中對維持產品完整性和延長保存期限的需求不斷成長
合約包裝涉及委託給第三方服務提供者。當客戶需要擴充性、上市速度和成本效率而無需投資內部包裝設備時,他們更喜歡這個細分市場。成本節約、專業知識、最尖端科技和法規遵循是合約包裝的關鍵驅動力。機構藥局是指位於醫院、診所和療養院等設施內的藥局。這些設施需要有效的包裝,以保持藥物的完整性並促進高周轉率患者照護環境中的藥物依從性。我們專注於針對患者的單位劑量包裝,以提高安全性、減少浪費並遵守嚴格的法規。藥品製造部門包括從事藥品和藥物製造的公司。這些製造商優先考慮保護產品完整性、延長保存期限並符合各個市場法規的包裝。這強調客製化、阻隔性以及遵守 FDA 和 EMA 指南等國際標準。零售藥局是藥品和消費者之間最直接的接觸點,需要包裝能保護藥品、影響消費者行為並展現品牌形象。消費者便利性、兒童、資訊展示和品牌塑造是零售藥局的核心偏好。
區域洞察
受其先進的醫療基礎設施、嚴格的法規結構和對藥物輸送解決方案的高需求的推動,美國已將自己定位為藥品包裝的領先國家。在投資和舉措方面,美國市場的生技藥品領域正在顯著成長,需要為敏感產品提供複雜的包裝解決方案。該地區的公司繼續申請創新包裝設計和材料的專利。在南美洲,巴西和阿根廷等國家的醫療保健支出不斷增加,醫療保健服務的普及正在推動藥品包裝的成長。歐盟國家的藥品包裝市場受到嚴格監管,並專注於病人安全和防偽措施。以病人為中心的設計和符合依從性的包裝是全部區域消費者的主要需求。客戶往往更喜歡整合安全功能並促進永續性的包裝。歐盟的措施通常包括開發環保包裝材料和回收計畫。在中東富裕國家,對符合國際標準的高品質藥品包裝的需求不斷成長。非洲有限的資源往往強調經濟實惠且功能齊全的包裝解決方案。然而,人們重新關注提高品質和打擊假藥。由於醫療保健產業的快速開拓、醫療支出的增加和老年人口的不斷增加,亞太地區的新興市場目前是全球成長最快的市場,特別是在中國、日本和澳洲等國家。中國政府促進醫藥創新的政策提高了客戶對先進包裝的期望。日本藥品包裝市場正在發展,注重精度、品質和產品完整性。人口老化正在增加消費者對易於使用且適合年齡的包裝的需求。印度作為重要的學名藥出口國,其藥品包裝市場具有成本效益的特性。
FPNV定位矩陣
FPNV定位矩陣對於評估藥品包裝市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對藥品包裝市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1. 醫藥包裝市場的市場規模與預測是多少?
2.在醫藥包裝市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3. 藥品包裝市場的技術趨勢和法規結構是什麼?
4.醫藥包裝市場主要供應商的市場佔有率為何?
5. 進入醫藥包裝市場適合的型態和策略手段是什麼?
[183 Pages Report] The Pharmaceutical Packaging Market size was estimated at USD 156.87 billion in 2023 and expected to reach USD 173.13 billion in 2024, at a CAGR 10.06% to reach USD 307.05 billion by 2030.
Pharmaceutical packaging refers to the processes and materials used to encase and protect pharmaceutical products. It includes a range of container types like bottles, vials, blisters, tubes, syringes, ampoules, closures, labels, and secondary packaging materials. The packaging is designed to provide barrier protection, convenience in handling, and convey essential information about the medications. Pharmaceutical packaging has a critical role in ensuring the safety, quality, and efficacy of drugs. It serves numerous applications, including providing barrier protection against environmental factors and child resistance and accommodating the demands of specific modes of drug delivery. The primary end-users of pharmaceutical packaging are pharmaceutical manufacturers, healthcare providers, and patients. Growth in the pharmaceutical packaging market is influenced by several factors, such as growing smart packaging for patient engagement and identification, rising demand for primary pharmaceutical packaging, and increasing demand for biologics packaging. Moreover, stricter regulations for packaging in terms of child resistance and tamper-evidence boost innovation and compliance-related investments. However, the expansion of pharmaceutical packaging is hindered by the price volatility of pharmaceutical packaging raw materials, adherence to the global and local regulatory landscape, and meeting sustainability goals while maintaining the integrity of the packaging. On the other hand, the latest opportunities within the pharmaceutical packaging market include the evolution of nanotechnology due to innovative and new-generation packaging solutions, the emergence of eco-friendly and sustainable packaging solutions, and the customization of packaging for personalized treatment protocols.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 156.87 billion |
Estimated Year [2024] | USD 173.13 billion |
Forecast Year [2030] | USD 307.05 billion |
CAGR (%) | 10.06% |
Type: Increasing preference for blister packs for pharmaceutical packaging due to resistance against humidity and contaminants
Ampoules are small sealed glass or plastic vessels that are used to contain and protect a sample of a pharmaceutical from air, contamination, or tampering. They are typically used to store pharmaceuticals in liquid form and are ideal for single-use applications, maintaining sterility. Blister packs are pre-formed plastic packaging solutions that accommodate tablets or capsules, providing a barrier against external factors such as humidity and contaminants. They are extensively used due to their convenience for dose administration and adherence, with child-resistant designs being particularly preferred for safety purposes. Caps and closures are critical components of pharmaceutical packaging, providing the integrity and safety of the product. They range from simple screw caps to complex child-resistant and tamper-evident designs. Cartridges serve a purpose in the administration of drugs, especially for conditions like diabetes, where self-injection is common. They offer an alternative to vials for multi-dose applications and are preferred when using pen injectors. Labels and accessories are indispensable for pharmaceutical packaging, serving as branding and informational mediums and as anti-counterfeiting tools. Smart labels with RFID technology for tracking and temperature-sensitive labels for cold chain management are gaining traction. Plastic bottles are a common packaging choice for a wide range of pharmaceutical products, from liquid syrups to tablets. Demand for these is high due to their lightweight nature and durability. Importantly, manufacturers are now concentrating on producing recyclable plastic bottles to reduce environmental impact. Pouches, often used for powdered or granulated pharmaceutical products, offer lightweight and flexible packaging solutions. They are especially preferred for products that require protection from moisture and light. Pre-filled inhalers provide users with ready-to-administer doses of medication for conditions such as asthma and chronic obstructive pulmonary disease. Pre-filled syringes have become popular due to their ease of use, reduced risk of dosing errors, and efficient delivery of various injectables. Vials are small bottles typically used for holding liquid medications. They are essential for multi-dose applications and are prized for their compatibility with multiple drug types. Each pharmaceutical packaging type caters to different needs within the market. Ampoules and vials favor parenteral applications with an emphasis on sterility. Pre-filled options, such as syringes and inhalers, prioritize convenience and dose accuracy. Bottles and pouches are geared towards the over-the-counter market, where ease of transport and storage are key. Blister packs and cartridges are increasingly preferred for their patient adherence and ease of use features. Caps, closures, labels, and accessories play supporting roles across the board, focusing on securing the product and providing vital information. The recent trend across all categories is the shift towards sustainable materials and environmentally-friendly manufacturing processes.
End User: Rising demand in pharmaceutical manufacturing for maintaining product integrity and extending shelf life
Contract packaging, or pharma co-packing, involves outsourcing pharmaceutical packaging to a third-party service provider. Clients prefer this segment when they require scalability, speed to market, and cost-efficiency without investing in in-house packaging facilities. Cost savings, expertise, state-of-the-art technology, and regulatory compliance are the primary driving factors for contract packaging. Institutional pharmacy refers to pharmacies within institutions like hospitals, clinics, and nursing homes. These entities require efficient packaging that maintains medication integrity and promotes adherence in high-turnover patient care settings. Emphasis is on patient-specific, unit-dose packaging, which enhances safety, reduces waste, and complies with stringent regulations. The Pharmaceutical manufacturing segment encompasses companies involved in the production of drugs and medications. These manufacturers prioritize packaging that protects product integrity, extends shelf life, and complies with regulations across various markets. This focuses on customization, barrier properties, and compliance with international standards such as FDA and EMA guidelines. Retail pharmacy is the most direct interface between medications and consumers, with packaging that safeguards the medication, influences consumer behaviors, and presents brand identity. Consumer convenience, child-resistant features, informational labeling, and branding are the core preferences for retail pharmacies.
Regional Insights
The United States stands as a prominent country for pharmaceutical packaging, driven by advanced healthcare infrastructure, stringent regulatory frameworks, and a high demand for drug delivery solutions. Regarding investments and initiatives, the US market is witnessing substantial growth in the biologics sector, necessitating sophisticated packaging solutions for sensitive products. Companies in the region continuously file patents for groundbreaking packaging designs and materials. In South America, rising healthcare expenditures and increasing access to healthcare services in countries such as Brazil and Argentina facilitate the growth of pharmaceutical packaging. The pharmaceutical packaging market in EU countries is highly regulated, focusing on patient safety and anti-counterfeiting measures. Patient-centric designs and adherence-compliant packaging are primary consumer needs across this region. Customers tend to favor packaging that integrates security features and promotes sustainability. EU initiatives often involve developing eco-friendly packaging materials and recycling programs. In wealthier nations within the Middle East, there is an increasing demand for high-quality pharmaceutical packaging that aligns with international standards. Africa, being a resource-limited setting, tends to focus on affordable and functional packaging solutions. However, there is an emerging focus on improving quality and counteracting counterfeit medications. The pharmaceutical packaging market in the APAC region is currently the fastest-growing globally due to rapidly developing healthcare sectors, increased healthcare spending, and a growing elderly population, especially in countries such as China, Japan, and Australia. The Chinese government's policies promoting innovation in pharmaceuticals have increased customer expectations for advanced packaging. Japan's pharmaceutical packaging market is developed, emphasizing precision, quality, and product integrity. The aging population leads to a consumer need for easy-to-use and senior-friendly packaging. India's pharmaceutical packaging market is characterized by cost-effectiveness due to the country's role as a significant exporter of generic drugs.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Packaging Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Packaging Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Pharmaceutical Packaging Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amcor PLC, AptarGroup, Inc., Becton, Dickinson and Company, Berry Global, Inc., Catalent, Inc., CCL Industries Inc., Comar, LLC, Constantia Flexibles, Drug Plastics Group, EPL Limited, Gaplast GmbH, Gerresheimer AG, Klockner Pentaplast Group, Lonza Group AG, McKesson Corporation, Mondi PLC, Nipro Corporation, Nolato AB, Origin Pharma Packaging, Schott AG, Sealed Air Corporation, SGD S.A., URSATEC GmbH, Vetter Pharma-Fertigung GmbH & Co. KG, W. L. Gore & Associates Inc., West Pharmaceutical Services, Inc., and Westrock Company by Smurfit Kappa Group.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Pharmaceutical Packaging Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Packaging Market?
3. What are the technology trends and regulatory frameworks in the Pharmaceutical Packaging Market?
4. What is the market share of the leading vendors in the Pharmaceutical Packaging Market?
5. Which modes and strategic moves are suitable for entering the Pharmaceutical Packaging Market?